Malignant pleural effusion (MPE) is a common but serious condition that is related with poor
quality of life, morbidity and mortality. Its incidence and associated healthcare costs are …

Symptomatic malignant pleural effusion is a common clinical problem. This condition is
associated with very high mortality, with life expectancy ranging from 3 to 12 months. Studies …

Background Malignant pleural effusion (MPE) is a common complication of advanced
malignancy, but little is known regarding its prevalence and overall burden on a population …

Objective To accurately evaluate the diagnostic value of carcinoembryonic antigen (CEA) for
malignant pleural effusion associated with lung cancer in the Chinese population. Methods …

Malignant pleural effusion (MPE) can complicate most malignancies and is a common
clinical problem presenting to respiratory and cancer care physicians. Despite its frequent …

Background Talc pleurodesis is an effective treatment for malignant pleural effusions
(MPEs). This study was designed to estimate complication rates of thoracoscopic talc …

Introduction: Optimal management of malignant pleural effusion (MPE) is important in the
care of patients with advanced cancer. Surgical (especially video-assisted thoracoscopic …

The incidence of empyema is increasing and associated with a mortality rate of 20% in
patients older than 65 years. Since 30% of patients with advanced empyema have …

Background Endostar is a new endogenous angiogenic inhibitor with implicated anti-tumor
activity. This study was to investigate whether thoracic perfusion of Endostar could be used …

Background VEGF is critical in the pathogenesis of malignant pleural effusion (MPE). To
understand the clinical benefits of antiangiogenic agents, the efficacy of chemotherapy …